Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Nov. 17, 2026. Document 2026-23351. Updated Nov. 18, 2026.
Read our story about this rule
Open for public comment until Jan. 19, 2027. Comment on Regulations.gov
- What it does
The Food and Drug Administration (FDA or we) is proposing to issue a regulation finding that N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action, if finalized, would allow products containing NAC to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the FD&C Act. We also propose to provide that the addition of NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act.
The Food and Drug Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- Before this
No earlier Federal Register document under regulation identifier 0910-AI91 since Jan. 1, 2025.
- What happens next and when
Either electronic or written comments on the proposed rule must be submitted by January 19, 2027.
The agency's dates, word for word.
The record as published
| Document number | 2026-23351 |
|---|---|
| Action | Proposed rule. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | Nov. 17, 2026 |
| Comments close | Jan. 19, 2027 |
| Regulation identifier (RIN) | 0910-AI91 |
| Docket | FDA-2025-N-2699 |
| Significant (marked in the Federal Register) | Yes |
Source: the Federal Register (public domain). The document in the Federal Register